Skip to main content

Table 2 Study outcomes in children with and without Mucopolysaccharidosis

From: Post-tonsillectomy outcomes in children with mucopolysaccharidosis and obstructive sleep apnea

Outcome

MPS

No MPS

P

Length of stay (days, IQR)

3 (1–4)

1 (1–2)

 < 0.001

Total Cost (USD, IQR)

33,016 (23,208–72,280)

15,383 (9937–24,462)

 < 0.001

Rate of PTH

15%

2.4%

 < 0.001

Rate of Respiratory Complications

10%

1.8%

 < 0.001

  1. MPS mucopolysaccharidosis, IQR interquartile range, USD U.S. Dollars, NS not significant, PTH post-tonsillectomy hemorrhage